LymphaCor Therapeutics Inc., is an RNA therapeutics company focused on alleviating inflammatory pathologies associated with the lymphatic system. LymphaCor is leveraging its core strengths in miRNA profiling, lymphatic dysfunction, medicinal chemistry, in vitro and in vivo analyses in different inflammatory disease models to screen, identify and modify specific target regulatory RNA in lymphatic disease specific pathways.
